Key result
Integrated genomic and transcriptomic analysis identifies SH2B3 as a key driver of blood pressure regulation.
Observational (n=3,679)
Answers are grounded in this paper and cite their sources.
Genome-wide association studies (GWAS) have identified numerous loci associated with blood pressure (BP). The molecular mechanisms underlying BP regulation, however, remain unclear. We investigated BP-associated molecular mechanisms by integrating BP GWAS with whole blood mRNA expression profiles in 3,679 individuals, using network approaches. BP transcriptomic signatures at the single-gene and the coexpression network module levels were identified. Four coexpression modules were identified as potentially causal based on genetic inference because expression-related SNPs for their corresponding genes demonstrated enrichment for BP GWAS signals. Genes from the four modules were further projected onto predefined molecular interaction networks, revealing key drivers. Gene subnetworks entailing molecular interactions between key drivers and BP-related genes were uncovered. As proof-of-concept, we validated SH2B3, one of the top key drivers, using Sh2b3(-/-) mice. We found that a significant number of genes predicted to be regulated by SH2B3 in gene networks are perturbed in Sh2b3(-/-) mice, which demonstrate an exaggerated pressor response to angiotensin II infusion. Our findings may help to identify novel targets for the prevention or treatment of hypertension.
No takes yet. Share an insight, caveat, or question.
Huan et al. (2015) conducted an observational in Blood pressure regulation (n=3,679). Genetic loci and whole blood mRNA expression profiles was evaluated on Blood pressure-associated transcriptomic signatures and key driver genes. Integration of GWAS and mRNA expression in 3,679 individuals identified SH2B3 as a key driver of blood pressure regulation, which was validated in Sh2b3(-/-) mice.
Synapse has enriched 10 related papers. Consider them for comparative context: